ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
100% Recruitment in Synovial Fluid Biomarker Trial
Published: 01/07/22, 08:30am (AEST)•3 pages